Biomotion Sciences Ordinary Shares (SLXN)
US$ 0.93430.46%
Price Chart
Key Statistics
Market Cap
$ 9.87M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
387.81K
52W High
$ 13.56
52W Low
$ 0.21
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
7.6153
200-Day MA
10.2693
52 Week High
13.5571
52 Week Low
0.2066
About SLXN
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in .
Employees
11
Headquarters
Jerusalem, Israel
CEO
Mr. Ilan Hadar M.B.A.
Latest News
Silexion Therapeutics Announces Pricing of $5.0 Million Public Offering - GlobeNewswire
2025-01-15 • Google News
SLXN stock touches 52-week low at $0.82 amid sharp annual decline - Investing.com
2025-01-21 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg